Back to Trials
NCT07104825NARecruiting

Autonomic Neural Blockade in Bariatric Surgery

Endeavor Health

Start Date

2/5/2026

Completion Date

12/1/2027

Summary

The purpose of this research is to evaluate if autonomic nerve block (ANB- blocking pain and nausea signals) decreases pain and anti-nausea medication requirements as well as the experience of pain/nausea during the first 72 hours after sleeve gastrectomy or gastric bypass surgery. Participants will be randomly assigned either to the standard of care or the ANB group before surgery. As part of standard of care, in both groups, laparoscopic bariatric surgery will be initiated with local anesthetic injected into the abdominal wall. In the ANB group, participants will be given an additional injection of local anesthetic medication to block nerves on and around the stomach.

Detailed Description

Gastric bypass and sleeve gastrectomy are the most common and successful weight loss surgeries. The advancement of laparoscopic, minimally invasive techniques allows these procedures to be performed with low morbidity and a relatively easy recovery, when broadly considering abdominal surgery. The major complaints postoperatively are abdominal pain and nausea, which can require medications to control and may prolong hospital stay. There is evidence autonomic neural blockade (ANB) improves pain and nausea in the immediate postoperative period. ANB has been shown to be therapeutic in the surgical environment providing extended analgesia for pain following surgery. This study is a single-blinded randomized controlled trial comparing the total morphine milligram equivalents (MMEs) of pain medication used 72 hours post-operative period in patients who received the ANB vs standard of care. In the ANB group, additional local anesthetic block of the neurovascular tissue along the lesser curve of the stomach and celiac trunk will be performed using 0.5% bupivacaine 10ml, 50mg and Liposomal bupivacaine 10ml, 133mg dose. Study participants will not be told if they received the block, but the surgeon will be aware of which study group participants are assigned.

Eligibility Criteria

Age Range: 18 years to 90 years

Inclusion Criteria: * Individuals able and willing to consent and participate in all study activities * Adults, ages 18-90 * All patients with severe obesity undergoing laparoscopic/robotic gastric bypass or sleeve gastrectomy Exclusion Criteria: * Patients taking opiates chronically * Patients allergic to study medications * Patients with any prior adverse reaction to ingredients included in the block * Adults unable to consent * Pregnant women * Prisoners

Interventions

PROCEDURE

Intraoperative autonomic neural blockade (ANB)

PROCEDURE

Laparoscopic Standard of Care Abdominal Wall Block

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Bariatric Surgery CandidatePain, PostoperativeNausea and Vomiting, PostoperativeOpioid Use

Locations

Endeavor Health

Evanston, Illinois 60201

United States